Resmed CEO Mick Farrell will become the next chair of AdvaMed’s board of directors. Farrell will serve a two-year term ...

Australia’s foremost chief executives have told the annual Chanticleer poll that governments need to step up and drive ...

AdvaMed announced today that it has named Resmed Chair and CEO Michael "Mick" Farrell as the next chair of its board of ...

According to TipRanks.com, Wright is a 5-star analyst with an average return of 14.3% and a 65.5% success rate. Wright covers the Healthcare sector, focusing on stocks such as BrightSpring Health ...

Your daily dose of the most interesting uptrends and downtrends on the ASX with technical analysis from an expert.

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

Let's see why these Australian stocks could be great options for investors with $2,000 to put to work in the share ...

ResMed has secured FDA clearance for its Personalized Therapy Comfort Settings (PTCS), branded as Smart Comfort - a ...

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s ...

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...